Conestoga Capital Advisors, LLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 75 filers reported holding IRADIMED CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Conestoga Capital Advisors, LLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q4 2016$5,601,000
-42.5%
504,600
-11.9%
0.37%
-44.1%
Q3 2016$9,733,000
+55.4%
572,885
+99.0%
0.67%
+44.1%
Q2 2016$6,263,000
+1.8%
287,835
-10.3%
0.46%
+11.3%
Q1 2016$6,151,000
+57.0%
321,010
+129.6%
0.42%
+31.2%
Q4 2015$3,919,000139,8050.32%
Other shareholders
IRADIMED CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 140,752$3,290,0003.17%
RK Capital 222,914$5,212,0001.95%
Nine Ten Capital Management LLC 130,272$3,046,0000.76%
Parkman Healthcare Partners LLC 93,500$2,186,0000.63%
Ranger Investment Management 244,963$5,727,0000.38%
CADENCE CAPITAL MANAGEMENT LLC 107,043$2,503,0000.27%
ALGERT GLOBAL LLC 29,652$693,0000.21%
Mondrian Investment Partners LTD 163,939$3,833,0000.10%
NAVELLIER & ASSOCIATES INC 20,800$486,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 56,811$1,328,0000.04%
View complete list of IRADIMED CORP shareholders